PKCs play a diverse role in glioma development as the contribution of each PKC isoform depends on the phosphorylation of tyrosine residues, the presence of oncogenic mutations, the type of stimuli, and the cellular environment [226]. This evidence concerns the gene PRRT2 and central nervous system cancer.